ImmuCell CorporationICCCNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P5
Near historical low
vs 2Y Ago
-25.4x
Contraction
Streak
4 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -388.92% |
| Q3 2025 | -96.48% |
| Q2 2025 | -49.04% |
| Q1 2025 | 79.86% |
| Q4 2024 | 208.09% |
| Q3 2024 | 58.54% |
| Q2 2024 | -362.13% |
| Q1 2024 | 70.08% |
| Q4 2023 | 15.29% |
| Q3 2023 | 9.23% |
| Q2 2023 | 42.18% |
| Q1 2023 | -38.09% |
| Q4 2022 | -164.88% |
| Q3 2022 | 0.36% |
| Q2 2022 | -208.48% |
| Q1 2022 | 292.41% |
| Q4 2021 | -46.36% |
| Q3 2021 | 25.79% |
| Q2 2021 | 157.53% |
| Q1 2021 | 40.91% |
| Q4 2020 | -151.99% |
| Q3 2020 | 63.60% |
| Q2 2020 | -451.12% |
| Q1 2020 | 181.20% |
| Q4 2019 | 43.59% |
| Q3 2019 | 21.42% |
| Q2 2019 | -306.18% |
| Q1 2019 | 128.65% |
| Q4 2018 | -520.89% |
| Q3 2018 | 22.89% |
| Q2 2018 | -8.56% |
| Q1 2018 | 56.86% |
| Q4 2017 | 14.39% |
| Q3 2017 | -81.83% |
| Q2 2017 | -128.89% |
| Q1 2017 | 669.61% |
| Q4 2016 | 136.41% |
| Q3 2016 | 135.11% |
| Q2 2016 | -96.93% |
| Q1 2016 | 51.48% |